Asset
Oxcarbazepine
Supernus Pharmaceuticals Inc. Common Stock
Revenue
No revenue reported in loaded filings.
Clinical trials (0)
No records yet.
FDA applications (1)
| Application | Type | Applicant |
|---|---|---|
| NDA 202810 | NDA | SUPERNUS PHARMACEUTICALS INC |
Marketed products (3)
- OXTELLAR XR
- OXTELLAR XR
- OXTELLAR XR